Dinesh Patel, CEO of Protagonist Therapeutics, gifts 300 shares of stock, reflecting personal decisions in the pharmaceutical industry.
| Name | Protagonist Therapeutics, Inc |
|---|---|
| CIK | 0001377121 |
| Tickers | PTGX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 980505495 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (510) 474-0170 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Dinesh Patel, CEO of Protagonist Therapeutics, gifts 300 shares of stock, reflecting personal decisions in the pharmaceutical industry.
Protagonist Therapeutics, Inc. releases Q3 results, highlighting progress in its drug development pipeline and collaborations with major industry players.
Protagonist Therapeutics announces strong Q3 results, FDA approval of MIMRYLO, and plans for a new psoriasis treatment trial.
710 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-130668 | 5237 | ||||||
| 2026-11-17 | 144 | xsl144X01/primary_doc.xml | 0001104659-26-129246 | 001-37852 | 261567810 | 33 | 4554 | |||
| 2026-11-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-129244 | 5165 | ||||||
| 2026-11-06 | 10-Q | 10-Q | 0001104659-26-123620 | 001-37852 | 261529563 | 34 | 6740428 | 1 | 1 | |
| 2026-11-05 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-26-123351 | 001-37852 | 261527689 | 34 | 325108 | 1 | 1 |
| 2026-10-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-003834 | 005-89601 | 261491686 | 34 | 11207 | |||
| 2026-10-02 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-113279 | 22973 | ||||||
| 2026-09-30 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009883 | 001-37852 | 261427386 | 33 | 4913 | |||
| 2026-09-10 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-106831 | 20743 | ||||||
| 2026-09-08 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-105955 | 5236 | ||||||
| 2026-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000908834-26-000405 | 005-89601 | 261274961 | 34 | 49483 | |||
| 2026-08-12 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-095111 | 15187 | ||||||
| 2026-08-10 | 144 | xsl144X01/primary_doc.xml | 0001968582-26-000805 | 001-37852 | 261259216 | 33 | 5716 | |||
| 2026-08-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000527 | 005-89601 | 261252250 | 34 | 8278 | |||
| 2026-08-05 | S-8 POS | S-8 POS | 0001104659-26-091259 | 333-293749 | 261244773 | 33 | 109280 | |||
| 2026-08-05 | S-8 POS | S-8 POS | 0001104659-26-091257 | 333-285137 | 261244764 | 33 | 109280 | |||
| 2026-08-05 | S-8 POS | S-8 POS | 0001104659-26-091254 | 333-277409 | 261244750 | 33 | 109280 | |||
| 2026-08-05 | S-8 POS | S-8 POS | 0001104659-26-091249 | 333-270573 | 261244738 | 33 | 109271 | |||
| 2026-08-05 | S-8 POS | S-8 POS | 0001104659-26-091245 | 333-263097 | 261244720 | 33 | 109271 | |||
| 2026-08-05 | S-8 POS | S-8 POS | 0001104659-26-091242 | 333-254090 | 261244703 | 33 | 109271 | |||
| 2026-08-05 | S-8 POS | S-8 POS | 0001104659-26-091241 | 333-237066 | 261244691 | 33 | 109271 | |||
| 2026-08-05 | S-8 POS | S-8 POS | 0001104659-26-091239 | 333-230213 | 261244679 | 33 | 109271 | |||
| 2026-08-05 | S-8 POS | S-8 POS | 0001104659-26-091236 | 333-223500 | 261244668 | 33 | 109271 | |||
| 2026-08-05 | S-8 POS | S-8 POS | 0001104659-26-091235 | 333-216532 | 261244655 | 33 | 109271 | |||
| 2026-08-05 | S-8 POS | S-8 POS | 0001104659-26-091233 | 333-213120 | 261244648 | 33 | 109271 | |||
| 2026-08-05 | S-8 | FORM S-8 | 0001104659-26-091226 | 333-298024 | 261244636 | 33 | 213341 | 1 | 1 | |
| 2026-08-05 | 10-Q | 10-Q | 0001104659-26-091123 | 001-37852 | 261243821 | 34 | 6680490 | 1 | 1 | |
| 2026-08-05 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001104659-26-091099 | 001-37852 | 261243623 | 34 | 8452992 | 1 | 1 |
| 2026-06-25 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-077761 | 9419 | ||||||
| 2026-06-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006422 | 001-37852 | 261111369 | 33 | 6437 | |||
| 2026-06-18 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001104659-26-075777 | 001-37852 | 261103234 | 34 | 389823 | 1 | 1 |
| 2026-06-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-073049 | 13059 | ||||||
| 2026-06-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-005894 | 001-37852 | 261080072 | 33 | 5719 | |||
| 2026-06-01 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-069047 | 8945 | ||||||
| 2026-05-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-005290 | 001-37852 | 261044828 | 33 | 4988 | |||
| 2026-05-14 | 4/A | OWNERSHIP DOCUMENT | 0001104659-26-061476 | 9736 | ||||||
| 2026-05-12 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-059591 | 9307 | ||||||
| 2026-05-12 | 144 | xsl144X01/primary_doc.xml | 0001968582-26-000430 | 001-37852 | 26970036 | 33 | 5712 | |||
| 2026-05-12 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000283 | 005-89601 | 26966949 | 34 | 8374 | |||
| 2026-05-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-058860 | 17758 | ||||||
| 2026-05-08 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004264 | 001-37852 | 26958734 | 33 | 6900 | |||
| 2026-05-07 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004220 | 001-37852 | 26954935 | 33 | 4841 | |||
| 2026-05-07 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004218 | 001-37852 | 26954485 | 33 | 5458 | |||
| 2026-05-05 | 10-Q | 10-Q | 0001104659-26-055661 | 001-37852 | 26943692 | 34 | 6058814 | 1 | 1 | |
| 2026-05-05 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-26-055629 | 001-37852 | 26943101 | 34 | 275227 | 1 | 1 |
| 2026-04-30 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-000884 | 005-89601 | 26921820 | 34 | 7592 | |||
| 2026-04-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100121-26-000589 | 005-89601 | 26914287 | 34 | 7536 | |||
| 2026-04-28 | ARS | ARS | 0001104659-26-050443 | 001-37852 | 26908879 | 34 | 2111795 | |||
| 2026-04-28 | DEFA14A | DEFA14A | 0001104659-26-050440 | 001-37852 | 26908820 | 34 | 438551 | |||
| 2026-04-28 | DEF 14A | FORM- DEF 14A | 0001104659-26-050429 | 001-37852 | 26908719 | 34 | 3904304 | 1 | 1 | |
| 2026-04-24 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-048572 | 5245 | ||||||
| 2026-04-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-046110 | 5134 | ||||||
| 2026-04-21 | 144 | xsl144X01/primary_doc.xml | 0001104659-26-046107 | 001-37852 | 26880334 | 33 | 5749 | |||
| 2026-03-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-036319 | 9421 | ||||||
| 2026-03-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-036318 | 8688 | ||||||
| 2026-03-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-036317 | 13454 | ||||||
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-002110 | 005-89601 | 26803089 | 34 | 7357 | |||
| 2026-03-26 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003020 | 001-37852 | 26798083 | 33 | 4853 | |||
| 2026-03-26 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003018 | 001-37852 | 26798057 | 33 | 6229 | |||
| 2026-03-26 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003011 | 001-37852 | 26797982 | 33 | 7680 | |||
| 2026-03-25 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-034736 | 15738 | ||||||
| 2026-03-24 | 144 | xsl144X01/primary_doc.xml | 0001968582-26-000318 | 001-37852 | 26787767 | 33 | 6463 | |||
| 2026-02-25 | S-8 | FORM S-8 | 0001104659-26-019736 | 333-293749 | 26679455 | 33 | 199205 | 1 | 1 | |
| 2026-02-25 | 10-K | 10-K | 0001104659-26-019696 | 001-37852 | 26679116 | 34 | 12941373 | 1 | 1 | |
| 2026-02-25 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-26-019658 | 001-37852 | 26678583 | 34 | 296698 | 1 | 1 |
| 2026-02-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-017176 | 9041 | ||||||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-001404 | 001-37852 | 26643747 | 33 | 4858 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493215-26-000042 | 005-89601 | 26636753 | 34 | 12813 | |||
| 2026-02-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902219-26-000033 | 005-89601 | 26614256 | 34 | 15393 | |||
| 2026-02-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-011575 | 9068 | ||||||
| 2026-02-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000908834-26-000054 | 005-89601 | 26607705 | 34 | 64693 | |||
| 2026-02-06 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000988 | 001-37852 | 26607551 | 33 | 4908 | |||
| 2026-01-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-26-000253 | 005-89601 | 26582584 | 34 | 7194 | |||
| 2026-01-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-007129 | 27682 | ||||||
| 2026-01-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-007128 | 15274 | ||||||
| 2026-01-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-007127 | 16354 | ||||||
| 2026-01-27 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000710 | 001-37852 | 26567014 | 33 | 9052 | |||
| 2026-01-27 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000698 | 001-37852 | 26565338 | 33 | 7677 | |||
| 2026-01-26 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000681 | 001-37852 | 26560837 | 33 | 6969 | |||
| 2026-01-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000655 | 001-37852 | 26556938 | 33 | 8029 | |||
| 2026-01-23 | 144 | xsl144X01/primary_doc.xml | 0001968582-26-000059 | 001-37852 | 26556432 | 33 | 5065 | |||
| 2026-01-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-005443 | 5025 | ||||||
| 2026-01-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-005442 | 5110 | ||||||
| 2026-01-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-005440 | 4995 | ||||||
| 2026-01-21 | 144 | xsl144X01/primary_doc.xml | 0001104659-26-005438 | 001-37852 | 26548836 | 33 | 5152 | |||
| 2026-01-21 | 144 | xsl144X01/primary_doc.xml | 0001104659-26-005437 | 001-37852 | 26548831 | 33 | 4613 | |||
| 2026-01-21 | 144 | xsl144X01/primary_doc.xml | 0001104659-26-005435 | 001-37852 | 26548811 | 33 | 4480 | |||
| 2026-01-13 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-003386 | 7067 | ||||||
| 2026-01-12 | 8-K | FORM 8-K | 7.01,9.01 | 0001104659-26-002724 | 001-37852 | 26524735 | 34 | 13562274 | 1 | 1 |
| 2026-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-001479 | 7500 | ||||||
| 2026-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-001478 | 7549 | ||||||
| 2026-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-001477 | 8199 | ||||||
| 2026-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-001476 | 7520 | ||||||
| 2026-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-001475 | 7478 | ||||||
| 2026-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-001474 | 7670 | ||||||
| 2026-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-001472 | 7553 | ||||||
| 2026-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-001471 | 7586 | ||||||
| 2025-11-24 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-115399 | 5101 | ||||||
| 2025-11-19 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-114082 | 5027 | ||||||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-003110 | 005-89601 | 251486594 | 34 | 23542 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-004833 | 005-89601 | 251481421 | 34 | 11551 | |||
| 2025-11-06 | 10-Q | 10-Q | 0001104659-25-107816 | 001-37852 | 251459296 | 34 | 6826171 | 1 | 1 | |
| 2025-11-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-25-107753 | 001-37852 | 251458611 | 34 | 302687 | 1 | 1 |
| 2025-10-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-002687 | 005-89601 | 251401884 | 34 | 11120 | |||
| 2025-10-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-099252 | 10778 | ||||||
| 2025-10-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007903 | 001-37852 | 251388323 | 33 | 6434 | |||
| 2025-09-24 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-093046 | 5066 | ||||||
| 2025-09-22 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007415 | 001-37852 | 251330424 | 33 | 5728 | |||
| 2025-09-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-091352 | 5094 | ||||||
| 2025-08-29 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-085795 | 5066 | ||||||
| 2025-08-27 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-006453 | 001-37852 | 251265758 | 33 | 4997 | |||
| 2025-08-11 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000093751-25-000483 | 005-89601 | 251200262 | 34 | 8324 | |||
| 2025-08-06 | S-3ASR | S-3ASR | 0001104659-25-074748 | 333-289313 | 251190370 | 33 | 1250770 | 1 | 1 | |
| 2025-08-06 | 10-Q | 10-Q | 0001558370-25-010534 | 001-37852 | 251189986 | 34 | 6752165 | 1 | 1 | |
| 2025-08-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-25-074719 | 001-37852 | 251189718 | 34 | 304162 | 1 | 1 |
| 2025-07-28 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-071262 | 5402 | ||||||
| 2025-07-23 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-070104 | 10825 | ||||||
| 2025-07-22 | 144 | xsl144X01/primary_doc.xml | 0001968582-25-000616 | 001-37852 | 251140329 | 33 | 7197 | |||
| 2025-07-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-069011 | 5403 | ||||||
| 2025-06-26 | 8-K | FORM 8-K | 5.07 | 0001104659-25-063038 | 001-37852 | 251080433 | 34 | 208244 | 1 | 1 |
| 2025-06-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-060239 | 6617 | ||||||
| 2025-06-16 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-001771 | 005-89601 | 251051206 | 34 | 38535 | |||
| 2025-06-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-058597 | 14884 | ||||||
| 2025-06-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-004118 | 001-37852 | 251038289 | 33 | 6265 | |||
| 2025-06-09 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-004047 | 001-37852 | 251034746 | 33 | 5556 | |||
| 2025-05-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000093751-25-000309 | 005-89601 | 25938508 | 34 | 8226 | |||
| 2025-05-06 | 10-Q | 10-Q | 0001558370-25-006530 | 001-37852 | 25918192 | 34 | 5970175 | 1 | 1 | |
| 2025-05-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-25-045073 | 001-37852 | 25917689 | 34 | 302399 | 1 | 1 |
| 2025-04-30 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-042608 | 6951 | ||||||
| 2025-04-29 | ARS | ARS | 0001104659-25-041224 | 001-37852 | 25887662 | 34 | 20242420 | |||
| 2025-04-29 | DEFA14A | DEFA14A | 0001104659-25-041217 | 001-37852 | 25887441 | 34 | 1138156 | |||
| 2025-04-29 | DEF 14A | DEF 14A | 0001104659-25-041206 | 001-37852 | 25887164 | 34 | 3516303 | 1 | 1 | |
| 2025-04-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-001890 | 005-89601 | 25886134 | 34 | 11286 | |||
| 2025-04-23 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-038036 | 4996 | ||||||
| 2025-04-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-001475 | 005-89601 | 25828563 | 34 | 11400 | |||
| 2025-03-20 | 8-K | FORM 8-K | 8.01 | 0001104659-25-026135 | 001-37852 | 25756563 | 34 | 197751 | 1 | 1 |
| 2025-03-19 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-025535 | 5072 | ||||||
| 2025-03-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-001945 | 001-37852 | 25744977 | 33 | 5012 | |||
| 2025-03-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-024063 | 13033 | ||||||
| 2025-03-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-024062 | 13107 | ||||||
| 2025-03-13 | 144 | xsl144X01/primary_doc.xml | 0001972362-25-000299 | 001-37852 | 25736934 | 33 | 4995 | |||
| 2025-03-12 | 144 | xsl144X01/primary_doc.xml | 0001972362-25-000282 | 001-37852 | 25732967 | 33 | 4970 | |||
| 2025-03-11 | 8-K/A | FORM 8-K/A | 8.01,9.01 | 0001104659-25-022615 | 001-37852 | 25728759 | 34 | 342779 | 1 | 1 |
| 2025-03-10 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-25-021986 | 001-37852 | 25722244 | 34 | 341297 | 1 | 1 |
| 2025-03-05 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-021045 | 7182 | ||||||
| 2025-03-03 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-25-019516 | 001-37852 | 25693870 | 34 | 2782598 | 1 | 1 |
| 2025-02-21 | S-8 | FORM S-8 | 0001104659-25-016166 | 333-285137 | 25652730 | 33 | 221315 | 1 | 1 | |
| 2025-02-21 | 10-K | 10-K | 0001558370-25-001317 | 001-37852 | 25652528 | 34 | 13189815 | 1 | 1 | |
| 2025-02-21 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-25-015897 | 001-37852 | 25648457 | 34 | 310310 | 1 | 1 |
| 2025-02-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-015734 | 5116 | ||||||
| 2025-02-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000908834-25-000053 | 005-89601 | 25603869 | 34 | 58907 | |||
| 2025-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-001236 | 005-89601 | 25592239 | 34 | 12080 | |||
| 2025-01-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-004571 | 6550 | ||||||
| 2025-01-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-004570 | 5154 | ||||||
| 2025-01-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-004569 | 6521 | ||||||
| 2025-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-001435 | 7563 | ||||||
| 2025-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-001434 | 7491 | ||||||
| 2025-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-001432 | 7572 | ||||||
| 2025-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-001430 | 7396 | ||||||
| 2025-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-001429 | 7684 | ||||||
| 2025-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-001428 | 8212 | ||||||
| 2025-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-001427 | 7596 | ||||||
| 2025-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-001426 | 7566 | ||||||
| 2025-01-06 | 8-K | FORM 8-K | 5.02 | 0001104659-25-001304 | 001-37852 | 25511067 | 34 | 197096 | 1 | 1 |
| 2024-11-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-123809 | 20446 | ||||||
| 2024-11-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-123807 | 25910 | ||||||
| 2024-11-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-123806 | 13052 | ||||||
| 2024-11-27 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-001771 | 001-37852 | 241511834 | 33 | 6201 | |||
| 2024-11-26 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-001760 | 001-37852 | 241505953 | 33 | 5030 | |||
| 2024-11-26 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-001758 | 001-37852 | 241505949 | 33 | 4991 | |||
| 2024-11-25 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-001735 | 001-37852 | 241497429 | 33 | 4380 | |||
| 2024-11-25 | 144 | xsl144X01/primary_doc.xml | 0001968582-24-001046 | 001-37852 | 241495984 | 33 | 4815 | |||
| 2024-11-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-121501 | 5109 | ||||||
| 2024-11-19 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-120670 | 5034 | ||||||
| 2024-11-18 | 8-K | FORM 8-K | 1.01,8.01,9.01 | 0001104659-24-120165 | 001-37852 | 241471986 | 34 | 241941 | 1 | 1 |
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0000921895-24-002719 | 005-89601 | 241463005 | 34 | 280393 | |||
| 2024-11-12 | SC 13G/A | UnitedStates_13G__Protagonis.txt | 0000932471-24-001157 | 005-89601 | 241449407 | 34 | 6765 | |||
| 2024-11-07 | 10-Q | 10-Q | 0001558370-24-014888 | 001-37852 | 241436563 | 34 | 7075393 | 1 | 1 | |
| 2024-11-07 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-24-115303 | 001-37852 | 241435679 | 34 | 299512 | 1 | 1 |
| 2024-11-04 | SC 13G/A | UnitedStates_13G__Protagonis.txt | 0000932471-24-000563 | 005-89601 | 241422117 | 34 | 5800 | |||
| 2024-10-16 | SC 13G | Protagonist_Thera_Inc.htm | 0000093751-24-000765 | 005-89601 | 241374016 | 34 | 56187 | |||
| 2024-09-20 | 8-K | FORM 8-K | 5.02 | 0001104659-24-101688 | 001-37852 | 241313403 | 34 | 198493 | 1 | 1 |
| 2024-09-13 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-099838 | 14546 | ||||||
| 2024-09-12 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-099420 | 8793 | ||||||
| 2024-09-11 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-001324 | 001-37852 | 241293490 | 33 | 4899 | |||
| 2024-09-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-006924 | 001-37852 | 241290305 | 33 | 5721 | |||
| 2024-08-07 | SC 13G/A | us74366e1029_080724.txt | 0001086364-24-008384 | 005-89601 | 241183775 | 34 | 14112 | |||
| 2024-08-06 | 10-Q | 10-Q | 0001558370-24-011095 | 001-37852 | 241179557 | 34 | 8528874 | 1 | 1 | |
| 2024-08-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-24-086088 | 001-37852 | 241177061 | 34 | 312132 | 1 | 1 |
| 2024-07-26 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-083039 | 8796 | ||||||
| 2024-07-24 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-005589 | 001-37852 | 241138481 | 33 | 5721 | |||
| 2024-06-26 | 8-K | FORM 8-K | 5.03,5.07,9.01 | 0001104659-24-075162 | 001-37852 | 241073564 | 34 | 225919 | 1 | 1 |
| 2024-06-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-072307 | 5109 | ||||||
| 2024-06-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-070420 | 8800 | ||||||
| 2024-06-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-070419 | 5817 | ||||||
| 2024-06-07 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-004533 | 001-37852 | 241030314 | 33 | 5009 | |||
| 2024-06-07 | 144 | xsl144X01/primary_doc.xml | 0001968582-24-000473 | 001-37852 | 241029860 | 33 | 6316 | |||
| 2024-05-07 | 10-Q | 10-Q | 0001558370-24-007081 | 001-37852 | 24922881 | 34 | 6848509 | 1 | 1 | |
| 2024-05-07 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-24-058036 | 001-37852 | 24922435 | 34 | 301118 | 1 | 1 |
| 2024-04-26 | ARS | ARS | 0001104659-24-053023 | 001-37852 | 24884611 | 34 | 2328488 | |||
| 2024-04-26 | DEFA14A | DEFA14A | 0001104659-24-053013 | 001-37852 | 24884556 | 34 | 470766 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0001104659-24-052999 | 001-37852 | 24884392 | 34 | 2945465 | 1 | 1 | |
| 2024-04-19 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-049567 | 5003 | ||||||
| 2024-04-12 | PRE 14A | FORM-PRE14A | 0001104659-24-046797 | 001-37852 | 24841894 | 34 | 2960713 | 1 | 1 | |
| 2024-04-02 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-042744 | 5597 | ||||||
| 2024-04-01 | 144 | xsl144X01/primary_doc.xml | 0001968582-24-000271 | 001-37852 | 24809239 | 33 | 5759 | |||
| 2024-03-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-033132 | 6950 | ||||||
| 2024-03-01 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-030159 | 5596 | ||||||
| 2024-03-01 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-030157 | 9268 | ||||||
| 2024-03-01 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-030156 | 14510 | ||||||
| 2024-03-01 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-000296 | 001-37852 | 24712527 | 33 | 6091 | |||
| 2024-03-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-001667 | 001-37852 | 24710484 | 33 | 5005 | |||
| 2024-03-01 | 144 | xsl144X01/primary_doc.xml | 0001968582-24-000154 | 001-37852 | 24710316 | 33 | 7870 | |||
| 2024-02-29 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-000257 | 001-37852 | 24705538 | 33 | 4888 | |||
| 2024-02-28 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-028888 | 5180 | ||||||
| 2024-02-28 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-028886 | 5080 | ||||||
| 2024-02-27 | S-8 | FORM S-8 | 0001104659-24-028247 | 333-277409 | 24687832 | 33 | 79944 | |||
| 2024-02-27 | 10-K | 10-K | 0001558370-24-001850 | 001-37852 | 24687482 | 34 | 11791694 | 1 | 1 | |
| 2024-02-27 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-24-028208 | 001-37852 | 24686851 | 34 | 303492 | 1 | 1 |
| 2024-02-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-025685 | 5179 | ||||||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023959 | 005-89601 | 24640015 | 34 | 138547 | |||
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0000921895-24-000437 | 005-89601 | 24633127 | 34 | 280174 | |||
| 2024-02-14 | SC 13G/A | PROTAGONIST THERAPEUTICS, INC. | 0000902664-24-001573 | 005-89601 | 24632374 | 34 | 62826 | |||
| 2024-02-14 | SC 13G/A | PROTAGONIST THERAPEUTICS, INC. | 0000902664-24-001553 | 005-89601 | 24632250 | 34 | 65063 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021763 | 005-89601 | 24629309 | 34 | 13267 | |||
| 2024-02-07 | SC 13G/A | PROTAGONIST THERAPEUTICS, INC. | 0000902664-24-001166 | 005-89601 | 24602186 | 34 | 103317 | |||
| 2024-02-02 | SC 13G/A | ptgx_13ga.htm | 0000908834-24-000035 | 005-89601 | 24588979 | 34 | 507140 | |||
| 2024-01-31 | 8-K | FORM 8-K | 1.01 | 0001104659-24-008787 | 001-37852 | 24582888 | 34 | 214087 | 1 | 1 |
| 2024-01-24 | SC 13G/A | us74366e1029_012424.txt | 0001086364-24-002344 | 005-89601 | 24555911 | 34 | 13854 | |||
| 2024-01-23 | SC 13G/A | Protagonist_Th_Inc.txt | 0000093751-24-000104 | 005-89601 | 24550970 | 34 | 8713 | |||
| 2024-01-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-004901 | 5092 | ||||||
| 2024-01-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-004899 | 5063 | ||||||
| 2024-01-16 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-24-003903 | 001-37852 | 24533698 | 34 | 5580348 | 1 | 1 |
| 2024-01-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-003435 | 8749 | ||||||
| 2024-01-09 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000244 | 001-37852 | 24524195 | 33 | 4931 | |||
| 2024-01-08 | 8-K | FORM 8-K | 7.01,9.01 | 0001104659-24-002073 | 001-37852 | 24518399 | 34 | 12795897 | 1 | 1 |
| 2024-01-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-001497 | 5747 | ||||||
| 2024-01-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-001496 | 5676 | ||||||
| 2024-01-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-001495 | 7576 | ||||||
| 2024-01-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-001494 | 5757 | ||||||
| 2024-01-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-001493 | 5580 | ||||||
| 2024-01-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-001492 | 7678 | ||||||
| 2024-01-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-001491 | 5683 | ||||||
| 2024-01-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-001490 | 9252 | ||||||
| 2024-01-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-001489 | 7561 | ||||||
| 2023-12-18 | SC 13G | PROTAGONIST THERAPEUTICS, INC. | 0000902664-23-005906 | 005-89601 | 231493920 | 34 | 70114 | |||
| 2023-12-15 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-126419 | 5516 | ||||||
| 2023-12-13 | 144 | xsl144X01/primary_doc.xml | 0001968582-23-000772 | 001-37852 | 231484930 | 33 | 4718 | |||
| 2023-11-02 | 10-Q | 10-Q | 0001558370-23-017460 | 001-37852 | 231373482 | 34 | 6511532 | 1 | 1 | |
| 2023-11-02 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-23-113828 | 001-37852 | 231373112 | 34 | 286460 | 1 | 1 |
| 2023-10-30 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-112599 | 5671 | ||||||
| 2023-10-30 | 3 | OWNERSHIP DOCUMENT | 0001104659-23-112596 | 9412 | ||||||
| 2023-10-30 | 8-K | FORM 8-K | 5.02 | 0001104659-23-112592 | 001-37852 | 231360722 | 34 | 199922 | 1 | 1 |
| 2023-10-23 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-110803 | 7187 | ||||||
| 2023-10-19 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-110157 | 7322 | ||||||
| 2023-08-11 | 424B5 | 424B5 | 0001104659-23-090520 | 333-227216 | 231164631 | 33 | 18345 | |||
| 2023-08-03 | 10-Q | 10-Q | 0001558370-23-013245 | 001-37852 | 231140395 | 34 | 7253744 | 1 | 1 | |
| 2023-08-03 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-23-087269 | 001-37852 | 231140142 | 34 | 278343 | 1 | 1 |
| 2023-07-05 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-23-077821 | 001-37852 | 231066693 | 34 | 27885879 | 1 | 1 |
| 2023-07-03 | 8-K | FORM 8-K | 3.01 | 0001104659-23-077599 | 001-37852 | 231065339 | 34 | 199036 | 1 | 1 |
| 2023-06-02 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-067691 | 7434 | ||||||
| 2023-06-02 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-067690 | 9141 | ||||||
| 2023-06-02 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-067689 | 7197 | ||||||
| 2023-05-30 | 8-K | FORM 8-K | 5.07 | 0001104659-23-066057 | 001-37852 | 23976720 | 34 | 206477 | 1 | 1 |
| 2023-05-04 | 10-Q | 10-Q | 0001558370-23-008137 | 001-37852 | 23889389 | 34 | 6401181 | 1 | 1 | |
| 2023-05-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-23-056018 | 001-37852 | 23889032 | 34 | 271306 | 1 | 1 |
| 2023-04-19 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-047208 | 5384 | ||||||
| 2023-04-13 | SC 13G | PROTAGONIST THERAPEUTICS, INC. | 0000902664-23-002591 | 005-89601 | 23818701 | 34 | 110254 | |||
| 2023-04-12 | ARS | ARS | 0001104659-23-044685 | 001-37852 | 23816464 | 34 | 2974613 | |||
| 2023-04-12 | DEFA14A | DEFA14A | 0001104659-23-044563 | 001-37852 | 23815685 | 34 | 446305 | |||
| 2023-04-12 | DEF 14A | DEF 14A | 0001104659-23-044557 | 001-37852 | 23815661 | 34 | 2651803 | |||
| 2023-04-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-044168 | 7299 | ||||||
| 2023-04-10 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-23-043353 | 001-37852 | 23809785 | 34 | 596432 | 1 | 1 |
| 2023-04-06 | 424B5 | 424B5 | 0001104659-23-042274 | 333-266595 | 23803795 | 33 | 995686 | |||
| 2023-04-04 | 424B5 | 424B5 | 0001104659-23-041529 | 333-266595 | 23798076 | 33 | 996068 | |||
| 2023-03-20 | SC 13G | SCHEDULE 13G | 0000921895-23-000729 | 005-89601 | 23747053 | 34 | 291156 | |||
| 2023-03-15 | S-8 | FORM S-8 | 0001104659-23-032859 | 333-270573 | 23736015 | 33 | 74367 | |||
| 2023-03-15 | 10-K | 10-K | 0001558370-23-003906 | 001-37852 | 23735867 | 34 | 11919506 | 1 | 1 | |
| 2023-03-15 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-23-032774 | 001-37852 | 23735274 | 34 | 287367 | 1 | 1 |
| 2023-03-10 | 8-K | FORM 8-K | 7.01 | 0001104659-23-031135 | 001-37852 | 23723394 | 34 | 199340 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SCHEDULE 13G/A, AMENDMENT #2 | 0000899140-23-000381 | 005-89601 | 23629305 | 34 | 53303 | |||
| 2023-02-14 | SC 13G/A | PROTAGONIST THERAPEUTICS, INC. | 0000902664-23-001711 | 005-89601 | 23623815 | 34 | 63324 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 6 TO THE SCHEDULE 13G | 0000921895-23-000478 | 005-89601 | 23620685 | 34 | 282455 | |||
| 2023-02-09 | SC 13G/A | 13ga5_protagonist.htm | 0001175707-23-000047 | 005-89601 | 23607058 | 34 | 680821 | |||
| 2023-02-09 | SC 13G | SCHEDULE 13G | 0001104659-23-016776 | 005-89601 | 23604058 | 34 | 13156 | |||
| 2023-01-31 | SC 13G/A | us74366e1029_013123.txt | 0001306550-23-005158 | 005-89601 | 23571822 | 34 | 13544 | |||
| 2023-01-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-004739 | 11484 | ||||||
| 2023-01-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-004737 | 11203 | ||||||
| 2023-01-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-004735 | 5524 | ||||||
| 2023-01-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-004734 | 11366 | ||||||
| 2023-01-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-004732 | 11471 | ||||||
| 2023-01-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-004731 | 11405 | ||||||
| 2023-01-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-004730 | 7411 | ||||||
| 2023-01-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-004725 | 7158 | ||||||
| 2023-01-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-004722 | 7218 | ||||||
| 2023-01-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-004721 | 8901 | ||||||
| 2023-01-11 | SC 13G/A | SCHEDULE 13G/A FOR PROTAGONIST THERAPEUTICS, INC. ON BEHALF OF JOHNSON & JOHNSON | 0000904454-23-000019 | 005-89601 | 23523133 | 34 | 34492 | |||
| 2023-01-10 | SC 13G/A | Protagonist_Therapeutics_Inc.txt | 0000093751-23-000007 | 005-89601 | 23519731 | 34 | 10791 | |||
| 2023-01-06 | 8-K | FORM 8-K | 5.02 | 0001104659-23-001872 | 001-37852 | 23515467 | 34 | 199461 | 1 | 1 |
| 2023-01-03 | SC 13G | SC 13G | 0001104659-23-000357 | 005-89601 | 23502399 | 34 | 133618 | |||
| 2022-12-12 | SC 13G/A | filing.txt | 0000315066-22-001871 | 005-89601 | 221456266 | 34 | 8230 | |||
| 2022-11-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-119974 | 27488 | ||||||
| 2022-11-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-119971 | 7594 | ||||||
| 2022-11-17 | 3 | OWNERSHIP DOCUMENT | 0001104659-22-119967 | 9231 | ||||||
| 2022-11-08 | 10-Q | 10-Q | 0001558370-22-016908 | 001-37852 | 221369717 | 34 | 7905438 | 1 | 1 | |
| 2022-11-08 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-22-115933 | 001-37852 | 221369005 | 34 | 293938 | 1 | 1 |
| 2022-08-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-029621 | 7126 | ||||||
| 2022-08-16 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-08-16 16:00:00 | 9999999995-22-002399 | 333-266595 | 221172020 | 33 | 1903 | ||
| 2022-08-12 | CORRESP | filename1.htm | 0001104659-22-090043 | 7703 | ||||||
| 2022-08-09 | UPLOAD | filename1.pdf | 0000000000-22-008438 | 40376 | ||||||
| 2022-08-05 | S-3 | S-3 | 0001104659-22-086733 | 333-266595 | 221141360 | 33 | 1435864 | |||
| 2022-08-04 | 10-Q | 10-Q | 0001558370-22-012277 | 001-37852 | 221137537 | 34 | 7844843 | 1 | 1 | |
| 2022-08-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-22-086131 | 001-37852 | 221136645 | 34 | 296090 | 1 | 1 |
| 2022-07-11 | SC 13G/A | PROTAGONIST_THERAPEUTICS_INC.txt | 0000093751-22-000567 | 005-89601 | 221076313 | 34 | 10523 | |||
| 2022-06-10 | SC 13G/A | filing.txt | 0000315066-22-001626 | 005-89601 | 221008012 | 34 | 8158 | |||
| 2022-06-02 | 8-K | FORM 8-K | 5.07 | 0001104659-22-067589 | 001-37852 | 22990686 | 34 | 215543 | 1 | 1 |
| 2022-05-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-065869 | 5662 | ||||||
| 2022-05-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-065866 | 5591 | ||||||
| 2022-05-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-065863 | 5616 | ||||||
| 2022-05-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-065862 | 5672 | ||||||
| 2022-05-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-065860 | 5495 | ||||||
| 2022-05-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-065859 | 5598 | ||||||
| 2022-05-05 | 10-Q | 10-Q | 0001558370-22-007438 | 001-37852 | 22897288 | 34 | 7286822 | 1 | 1 | |
| 2022-05-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-056000 | 13012 | ||||||
| 2022-05-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-055995 | 7029 | ||||||
| 2022-05-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-22-055918 | 001-37852 | 22892662 | 34 | 294978 | 1 | 1 |
| 2022-04-26 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-050560 | 13527 | ||||||
| 2022-04-26 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-050551 | 13233 | ||||||
| 2022-04-26 | 8-K | FORM 8-K | 7.01,9.01 | 0001104659-22-049856 | 001-37852 | 22851626 | 34 | 5004741 | 1 | 1 |
| 2022-04-19 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-047468 | 7522 | ||||||
| 2022-04-19 | 3 | OWNERSHIP DOCUMENT | 0001104659-22-047462 | 9216 | ||||||
| 2022-04-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-046158 | 7025 | ||||||
| 2022-04-13 | DEFA14A | DEFA14A | 0001104659-22-045551 | 001-37852 | 22825324 | 34 | 5345196 | |||
| 2022-04-13 | DEF 14A | DEF 14A | 0001104659-22-045545 | 001-37852 | 22825301 | 34 | 2090880 | |||
| 2022-04-13 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-22-045517 | 001-37852 | 22825004 | 34 | 10653350 | 1 | 1 |
| 2022-03-31 | 8-K | FORM 8-K | 5.02 | 0001104659-22-041035 | 001-37852 | 22792642 | 34 | 205648 | 1 | 1 |
| 2022-03-23 | 8-K | FORM 8-K | 5.02 | 0001104659-22-037018 | 001-37852 | 22763211 | 34 | 200365 | 1 | 1 |
| 2022-03-02 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-029522 | 4934 | ||||||
| 2022-03-02 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-029520 | 5075 | ||||||
| 2022-03-02 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-029519 | 5023 | ||||||
| 2022-02-28 | S-8 | FORM S-8 | 0001104659-22-028156 | 333-263097 | 22690984 | 33 | 365319 | |||
| 2022-02-28 | 10-K | 10-K | 0001558370-22-002385 | 001-37852 | 22690740 | 34 | 11584071 | 1 | 1 | |
| 2022-02-28 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-22-028113 | 001-37852 | 22690083 | 34 | 343599 | 1 | 1 |
| 2022-02-22 | 8-K | FORM 8-K | 5.02 | 0001104659-22-025661 | 001-37852 | 22658547 | 34 | 201966 | 1 | 1 |
| 2022-02-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-024841 | 7415 | ||||||
| 2022-02-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-024840 | 7525 | ||||||
| 2022-02-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-024838 | 7435 | ||||||
| 2022-02-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-024835 | 7356 | ||||||
| 2022-02-14 | SC 13G/A | SCHEDULE 13G/A, AMENDMENT #1 | 0000899140-22-000317 | 005-89601 | 22633153 | 34 | 66757 | |||
| 2022-02-14 | SC 13G/A | CONSONANCE CAPITAL MANAGEMENT LP | 0001085146-22-001037 | 005-89601 | 22629186 | 34 | 46736 | |||
| 2022-02-14 | SC 13G/A | PROTAGONIST THERAPEUTICS, INC | 0000902664-22-001579 | 005-89601 | 22625414 | 34 | 62124 | |||
| 2022-02-14 | SC 13G/A | AMENDMENT NO. 5 TO THE SCHEDULE 13G | 0000921895-22-000451 | 005-89601 | 22624172 | 34 | 289368 | |||
| 2022-02-11 | SC 13G/A | AMENDMENT #4 | 0000908834-22-000091 | 005-89601 | 22621257 | 34 | 458632 | |||
| 2022-02-10 | SC 13G | PROTAGONIST_THERAPEUTICS_INC.txt | 0000093751-22-000155 | 005-89601 | 22613668 | 34 | 8648 | |||
| 2022-02-09 | SC 13G/A | filing.txt | 0000315066-22-001301 | 005-89601 | 22604784 | 34 | 8627 | |||
| 2022-02-03 | SC 13G/A | us74366e1029_020222.txt | 0000834237-22-005353 | 005-89601 | 22585615 | 34 | 13570 | |||
| 2021-12-23 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-153135 | 5283 | ||||||
| 2021-11-03 | 10-Q | 10-Q | 0001558370-21-014338 | 001-37852 | 211376488 | 34 | 10317616 | 1 | 1 | |
| 2021-11-03 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-21-133637 | 001-37852 | 211375386 | 34 | 309420 | 1 | 1 |
| 2021-09-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-118054 | 7315 | ||||||
| 2021-09-21 | SC 13G | SCHEDULE 13G | 0000899140-21-000651 | 005-89601 | 211266904 | 34 | 67637 | |||
| 2021-09-17 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-21-117017 | 001-37852 | 211261437 | 34 | 229269 | 1 | 1 |
| 2021-08-19 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-107818 | 9420 | ||||||
| 2021-08-10 | 8-K | FORM 8-K | 1.01 | 0001104659-21-102543 | 001-37852 | 211158463 | 34 | 213240 | 1 | 1 |
| 2021-08-04 | 10-Q | 10-Q | 0001558370-21-010244 | 001-37852 | 211144622 | 34 | 8442629 | 1 | 1 | |
| 2021-08-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-21-100078 | 001-37852 | 211144165 | 34 | 303478 | 1 | 1 |
| 2021-07-28 | 8-K | FORM 8-K | 1.01 | 0001104659-21-096941 | 001-37852 | 211122642 | 34 | 226071 | 1 | 1 |
| 2021-06-17 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-21-082678 | 001-37852 | 211025488 | 34 | 626032 | 1 | 1 |
| 2021-06-17 | 424B5 | 424B5 | 0001104659-21-082601 | 333-251254 | 211024789 | 33 | 1150252 | |||
| 2021-06-14 | 424B5 | 424B5 | 0001104659-21-080855 | 333-251254 | 211015503 | 33 | 1200622 | |||
| 2021-06-14 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-21-080820 | 001-37852 | 211015187 | 34 | 3576811 | 1 | 1 |
| 2021-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-036680 | 5833 | ||||||
| 2021-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-036670 | 5818 | ||||||
| 2021-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-036667 | 5651 | ||||||
| 2021-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-036664 | 5751 | ||||||
| 2021-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-036663 | 5781 | ||||||
| 2021-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-036662 | 5759 | ||||||
| 2021-05-28 | 8-K | FORM 8-K | 5.07 | 0001104659-21-074317 | 001-37852 | 21981636 | 34 | 210419 | 1 | 1 |
| 2021-05-04 | 10-Q | 10-Q | 0001558370-21-005733 | 001-37852 | 21889480 | 34 | 7164182 | 1 | 1 | |
| 2021-05-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-21-060967 | 001-37852 | 21888442 | 34 | 289766 | 1 | 1 |
| 2021-04-14 | DEFA14A | DEFA14A | 0001104659-21-050207 | 001-37852 | 21825839 | 34 | 1302171 | |||
| 2021-04-14 | DEF 14A | DEF 14A | 0001104659-21-050202 | 001-37852 | 21825804 | 34 | 1856038 | |||
| 2021-03-10 | S-8 | FORM S-8 | 0001104659-21-034494 | 333-254090 | 21730304 | 33 | 85951 | |||
| 2021-03-10 | 10-K | 10-K | 0001558370-21-002715 | 001-37852 | 21730186 | 34 | 11515298 | 1 | 1 | |
| 2021-03-10 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-21-034431 | 001-37852 | 21729684 | 34 | 304139 | 1 | 1 |
| 2021-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-014984 | 7485 | ||||||
| 2021-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-014981 | 7388 | ||||||
| 2021-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-014976 | 7582 | ||||||
| 2021-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-014973 | 7476 | ||||||
| 2021-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-014967 | 7488 | ||||||
| 2021-02-17 | SC 13G | CONSONANCE CAPITAL MANAGEMENT LP | 0001085146-21-001026 | 005-89601 | 21643996 | 34 | 58445 | |||
| 2021-02-16 | SC 13G | CONSONANCE CAPITAL MANAGEMENT LP | 0001085146-21-000931 | 005-89601 | 21636238 | 34 | 57982 | |||
| 2021-02-16 | SC 13G/A | AMENDMENT NO. 4 TO THE SCHEDULE 13G | 0000921895-21-000409 | 005-89601 | 21631532 | 34 | 294939 | |||
| 2021-02-16 | SC 13G/A | AMENDMENT NO. 3 | 0001214659-21-001721 | 005-89601 | 21630859 | 34 | 312621 | |||
| 2021-02-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-010401 | 17465 | ||||||
| 2021-02-12 | SC 13G/A | form-sc13ga.htm | 0001493152-21-003507 | 005-89601 | 21623422 | 34 | 192642 | |||
| 2021-02-11 | SC 13G/A | PROTAGONIST THERAPEUTICS, INC. | 0000902664-21-001142 | 005-89601 | 21616811 | 34 | 108277 | |||
| 2021-02-08 | SC 13G/A | filing.txt | 0000315066-21-001243 | 005-89601 | 21599805 | 34 | 8646 | |||
| 2021-02-02 | SC 13G | us74366e1029_020221.txt | 0000834237-21-006869 | 005-89601 | 21580630 | 34 | 13392 | |||
| 2021-02-02 | SC 13G/A | SCHEDULE 13G/A | 0000904454-21-000100 | 005-89601 | 21578024 | 34 | 38451 |
One latest value per concept from companyfacts (356 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 65.27M | 2026-10-31 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 2.90B | 2025-06-30 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| ecd | AwardExrcPrice | AwardExrcPrice | USD/shares | 38.09 | 2025-01-06 | DEF 14A | 2026-04-28 | 0001104659-26-050429 | |||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 11.66M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001104659-26-050429 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 3.68M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001104659-26-050429 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 124.75 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001104659-26-050429 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 46.07M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001104659-26-050429 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 12.87M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001104659-26-050429 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 433.23 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001104659-26-050429 | ||
| ecd | UndrlygSecurityMktPriceChngPct | UndrlygSecurityMktPriceChngPct | pure | 0.5 | 2025-01-02 | DEF 14A | 2026-04-28 | 0001104659-26-050429 | |||
| ffd | NetFeeAmt | NetFeeAmt | USD | 12,126.35 | 2026-08-03 | S-8 | 2026-08-05 | 0001104659-26-091226 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 12,126.35 | 2026-08-03 | S-8 | 2026-08-05 | 0001104659-26-091226 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 87.81M | 2026-08-03 | S-8 | 2026-08-05 | 0001104659-26-091226 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-03 | S-8 | 2026-08-05 | 0001104659-26-091226 | |||
| srt | StockRepurchaseProgramAuthorizedAmount1 | StockRepurchaseProgramAuthorizedAmount1 | USD | 300.00M | 2026-09-08 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 5.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 3.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 11.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 4.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 26.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 642,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 9.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -1.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.18B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 42.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 25,000 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001558370-25-001317 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 33.81M | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 42.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 21,000 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001558370-20-005785 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 900,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | Assets | Assets | USD | 1.15B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 1.10B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 135.18M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001558370-18-008657 | |
| us-gaap | AvailableForSaleSecuritiesCurrent | Available-for-sale Securities, Current | USD | 42.47M | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-08 | 0001558370-19-004481 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value | USD | 100.01M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 | |
| us-gaap | AvailableForSaleSecuritiesGrossRealizedGainLossNet | Available-for-sale Securities, Gross Realized Gain (Loss) | USD | 0 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001377121-17-000007 |
| us-gaap | AvailableForSaleSecuritiesNoncurrent | Available-for-sale Securities, Noncurrent | USD | 11.46M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001558370-19-001853 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 54,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | CapitalizedContractCostNet | Capitalized Contract Cost, Net | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 498.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 17.03M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 498.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 369.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 457.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0.001 | 2023-08-31 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 1.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001558370-25-001317 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 2.56M | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 180.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 65.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 65.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | 384.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract | Contract with Customer, Asset, Cumulative Catch-up Adjustment to Revenue, Modification of Contract | USD | -8.19M | 2019-04-01 | 2019-06-30 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 |
| us-gaap | ContractWithCustomerAssetGrossCurrent | Contract with Customer, Asset, before Allowance for Credit Loss, Current | USD | 165.00M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001558370-25-001317 | |
| us-gaap | ContractWithCustomerAssetNet | Contract with Customer, Asset, after Allowance for Credit Loss | USD | 25.15M | 2022-03-31 | 2023 | Q1 | 10-Q | 2023-05-04 | 0001558370-23-008137 | |
| us-gaap | ContractWithCustomerAssetNetCurrent | Contract with Customer, Asset, after Allowance for Credit Loss, Current | USD | 4.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 6.30M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-05 | 0001104659-26-055661 | |
| us-gaap | ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized | Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized | USD | 8.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 3,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001558370-25-001317 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 23.79M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 22.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod | Contract with Customer, Performance Obligation Satisfied in Previous Period | USD | 0 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001558370-18-008657 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 66.90M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001558370-19-001853 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 8.58M | 2016-08-16 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 | |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 1.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 170.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 4.08M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | -88,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0001558370-23-003906 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 838,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 838,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 1.02M | 2015-01-01 | 2015-09-30 | 2016 | Q3 | 10-Q | 2016-11-14 | 0001193125-16-767928 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 10.00M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 | |
| us-gaap | DebtInstrumentInterestRateEffectivePercentage | Debt Instrument, Interest Rate, Effective Percentage | pure | 0.099 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.079 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 | |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 78,000 | 2023-01-01 | 2023-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0001558370-24-011095 |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 222,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 | |
| us-gaap | DeferredFinanceCostsNoncurrentGross | Debt Issuance Cost, Gross, Noncurrent | USD | 235,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 | |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 1.39M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0001558370-23-003906 |
| us-gaap | DeferredIncomeCurrent | Deferred Income, Current | USD | 16.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | DeferredIncomeTaxAssetsNet | Deferred Income Tax Assets, Net | USD | 1.43M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 1.39M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0001558370-23-003906 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 1.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 1.47M | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-09-15 | 0001193125-16-710986 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 799,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 31.75M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001558370-18-001637 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 11.68M | 2024-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 1.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 168.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNetNoncurrent | Deferred Tax Assets, Net, Noncurrent | USD | 478,000 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-08 | 0001558370-19-004481 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 1.43M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 54.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 1.10M | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 600,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 529,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 51.96M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 14.27M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other | USD | 908,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 167.14M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 1.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | DefinedContributionPlanAdministrativeExpenses | Defined Contribution Plan, Administrative Expense | USD | 200,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-04 | 0001558370-21-005733 |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 500,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 0 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0001558370-23-003906 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 0.5 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount | USD | 5,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | Depreciation | Depreciation | USD | 1.23M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | DueFromAffiliateCurrent | Due from Affiliate, Current | USD | 5.79M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-07 | 0001558370-18-006639 | |
| us-gaap | DueFromRelatedPartiesCurrent | Due from Related Parties, Current | USD | 39,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001558370-23-013245 | |
| us-gaap | DueToAffiliateCurrent | Due to Affiliate, Current | USD | 276,000 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-07 | 0001558370-18-006639 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 10,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001558370-23-013245 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | 5.88 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.27 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001558370-22-012277 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | 5.43 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.006 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.342 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | -0.312 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0.002 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001558370-25-001317 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | 0.049 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.017 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.006 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.037 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0.029 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001558370-25-001317 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations | Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations | USD | 22,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | -90,000 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001558370-25-001317 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 78.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001558370-19-001853 |
| us-gaap | ForeignCurrencyTransactionLossBeforeTax | Foreign Currency Transaction Loss, before Tax | USD | 549,000 | 2020-01-01 | 2020-03-31 | 2021 | Q1 | 10-Q | 2021-05-04 | 0001558370-21-005733 |
| us-gaap | ForeignIncomeTaxExpenseBenefitContinuingOperations | Foreign Income Tax Expense (Benefit), Continuing Operations | USD | -1.10M | 2019-01-01 | 2019-09-30 | 2020 | Q3 | 10-Q | 2020-11-04 | 0001558370-20-012597 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -8,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001558370-22-002385 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -585,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0001558370-23-003906 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 39.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -129.79M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | 393.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 476,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | IncomeTaxCreditsAndAdjustments | Income Tax Credits and Adjustments | USD | 1.44M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0001558370-23-003906 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 3.69M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | AUD | 3.80M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0001558370-23-003906 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 7.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 2.67M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 1.02M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 44.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -27.16M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 112,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | -6.35M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -2.19M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 838,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 4.78M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 696,000 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-08 | 0001558370-19-004481 |
| us-gaap | IncreaseDecreaseInAccountsPayableRelatedParties | Increase (Decrease) in Accounts Payable, Related Parties | USD | -3,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | 563,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | IncreaseDecreaseInAccountsReceivableRelatedParties | Increase (Decrease) in Accounts Receivable, Related Parties | USD | 155.00M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001558370-25-001317 |
| us-gaap | IncreaseDecreaseInAccruedIncomeTaxesPayable | Increase (Decrease) in Income Taxes Payable | USD | 4.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | IncreaseDecreaseInContractWithCustomerAsset | Increase (Decrease) in Contract with Customer, Asset | USD | 4.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 6.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 31.75M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001558370-18-001637 |
| us-gaap | IncreaseDecreaseInIncomeTaxesReceivable | Increase (Decrease) in Income Taxes Receivable | USD | -2.69M | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001558370-25-001317 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -1.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | -5.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 832,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | -121,000 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0001558370-24-001850 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -1.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | IncreaseInCarryingAmountOfRedeemablePreferredStock | Increase in Carrying Amount of Redeemable Preferred Stock | USD | 558,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 |
| us-gaap | InterestExpense | Interest Expense | USD | 598,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0001558370-23-003906 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 438,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0001558370-23-003906 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 68,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 | |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 3.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 20.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | LeaseCost | Lease, Cost | USD | 2.31M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 11.48M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 895,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-06 | 0001558370-19-010201 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 2.79M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 895,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 2.83M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 2.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 2.88M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 223,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001558370-24-014888 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | Liabilities | Liabilities | USD | 61.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 1.15B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 55.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 2.12M | 2015-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 9.79M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 | |
| us-gaap | LongTermDebtFairValue | Long-term Debt, Fair Value | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 301.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 34.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss | USD | 5,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 41.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 492,000 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001377121-17-000007 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 181.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | 11.07M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001377121-17-000007 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | 146.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | 18.02M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001377121-17-000007 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | 386.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -38.92M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001558370-19-001853 |
| us-gaap | NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 | Noncash or Part Noncash Acquisition, Fixed Assets Acquired | USD | 185,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 114.72M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001104659-26-091123 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | 373.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 2.31M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 1.50M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0001558370-24-001850 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 10.32M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 2.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 6.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 903,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 6.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 2.07M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001558370-25-001317 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 11.23M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 1.94M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 2.19M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 2.12M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 2.06M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 2.00M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 922,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 477,000 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001558370-18-008657 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 1.90M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.057 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | OtherAccountsPayableAndAccruedLiabilities | Other Accounts Payable and Accrued Liabilities | USD | 26.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 577,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 10,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 832,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | 73,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-06 | 0001558370-19-010201 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | USD | 194,000 | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | 21,000 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001377121-17-000007 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | 324,000 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001377121-17-000007 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -143,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -1.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -1.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 121,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001558370-22-002385 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -42,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | OtherOperatingActivitiesCashFlowStatement | Other Operating Activities, Cash Flow Statement | USD | -5,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 6.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 11,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001558370-23-013245 | |
| us-gaap | PaymentsForProceedsFromTenantAllowance | Payments for (Proceeds from) Tenant Allowance | USD | 469,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 5.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 14,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0001558370-23-003906 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 25,000 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001558370-22-012277 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecurities | Payments to Acquire Available-for-sale Securities | USD | 21.73M | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-08 | 0001558370-19-004481 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 212.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 620,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001377121-17-000007 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 13.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 190,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | ProceedsFromDebtNetOfIssuanceCosts | Proceeds from Debt, Net of Issuance Costs | USD | 24.30M | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001377121-17-000007 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 107.80M | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 991,000 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001558370-20-009681 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 9.77M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001558370-22-002385 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 22.51M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001558370-19-001853 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 46.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | ProceedsFromLeasePayments | Proceeds from Lease Payment, Operating Activity | USD | 341,000 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-06 | 0001558370-25-006530 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 391.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 3.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 32,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 151,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 789,000 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001377121-17-000007 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 559,000 | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | 386.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 12.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 3.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | ReceivablesLongTermContractsOrPrograms | Receivables, Long-term Contracts or Programs | USD | 283.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 10.52M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0001558370-23-003906 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 130.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 10,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 10,000 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0001558370-23-003906 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 287,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 300,000 | 2020-03-07 | 2021 | FY | 10-K | 2022-02-28 | 0001558370-22-002385 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -84.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 544.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 56.37M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-05 | 0001104659-26-055661 |
| us-gaap | RevenueFromRelatedParties | Revenue from Related Parties | USD | 20.06M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001558370-18-001637 |
| us-gaap | RevenueRemainingPerformanceObligation | Revenue, Remaining Performance Obligation, Amount | USD | 96.30M | 2021-03-31 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001558370-21-010244 | |
| us-gaap | Revenues | Revenues | USD | 8.78M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001377121-17-000007 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 10.51M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 20 | 2023-04-30 | 2023 | FY | 10-K | 2024-02-27 | 0001558370-24-001850 | |
| us-gaap | SecurityDeposit | Security Deposit | USD | 225,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-05 | 0001104659-26-055661 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 42.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 26,727 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001558370-20-009681 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 8.97 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001558370-20-009681 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 142,000 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001558370-20-009681 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 7.8 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001558370-20-009681 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 262,608 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001558370-20-009681 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 9.24 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001558370-20-009681 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 131,147 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001558370-20-009681 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 9.52 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001558370-20-009681 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001558370-23-013245 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.525 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001558370-18-001637 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.902 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001558370-21-010244 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.88 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001558370-21-010244 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.02 | 2017-07-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001377121-17-000007 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.011 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001558370-21-010244 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.001 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001558370-21-010244 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 362.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 5.35M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 19.58 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 39.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.11M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 32.48 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 501.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 7.67M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 21.99 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 29.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 501.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 7.67M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 21.99 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 20.64 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 26.28 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 40.93 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 51,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 1.08B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.069 | 2016-07-01 | 2016-07-31 | 2017 | FY | 10-K | 2018-03-07 | 0001558370-18-001637 |
| us-gaap | StockIssued1 | Stock Issued | USD | 1.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 5.00M | 2023-04-01 | 2023-04-30 | 2023 | FY | 10-K | 2024-02-27 | 0001558370-24-001850 |
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited | Stock Issued During Period, Shares, Restricted Stock Award, Forfeited | shares | 200,110 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 1.06M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 66.90M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001558370-19-001853 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 24.30M | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-04 | 0001558370-23-008137 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 48.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 151,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001558370-19-001853 |
| us-gaap | StockRepurchasedAndRetiredDuringPeriodValue | Stock Repurchased and Retired During Period, Value | USD | 6.67M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 |
| us-gaap | StockRepurchasedDuringPeriodShares | Stock Repurchased During Period, Shares | shares | 40,560 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 5.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 | Stock Repurchase Program, Remaining Authorized Repurchase Amount | USD | 294.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | SubleaseIncome | Sublease Income | USD | 34,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | TangibleAssetImpairmentCharges | Tangible Asset Impairment Charges | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-10 | 0001558370-21-002715 |
| us-gaap | TemporaryEquityAccretionToRedemptionValue | Temporary Equity, Accretion to Redemption Value | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001558370-19-001853 |
| us-gaap | TemporaryEquityAccretionToRedemptionValueAdjustment | Temporary Equity, Accretion to Redemption Value, Adjustment | USD | 558,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001558370-19-001853 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 37.00M | 2015-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001558370-19-001853 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 41.54M | 2015-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001558370-19-001853 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 126.37M | 2015-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001558370-19-001853 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001193125-17-073383 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0001558370-23-003906 | |
| us-gaap | TreasuryStockCommonValue | Treasury Stock, Common, Value | USD | 5.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 36.97M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 902,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 5.33M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 1.07M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 4.10M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-10 | 0001558370-20-002334 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 51.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001104659-26-019696 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 5.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 71.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 48.90M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001558370-22-012277 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 65.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001104659-26-123620 |